Blood factors as biomarkers in osteoporosis: points from the COVID-19 era.
COVID-19
monocyte
osteoporosis
platelets
spontaneous osteoclastogenesis
Journal
Trends in endocrinology and metabolism: TEM
ISSN: 1879-3061
Titre abrégé: Trends Endocrinol Metab
Pays: United States
ID NLM: 9001516
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
19
02
2021
revised:
18
05
2021
accepted:
24
05
2021
pubmed:
12
7
2021
medline:
24
8
2021
entrez:
11
7
2021
Statut:
ppublish
Résumé
The restrictions adopted during the coronavirus disease 2019 (COVID-19) pandemic limiting direct medical consultations and access to healthcare centers reduced the participation of patients with chronic diseases, such as osteoporosis (OP), in screening and monitoring programs. This highlighted the need for new screening diagnostic tools that are clinically effective, but require minimal technical and time commitments, to stratify populations and identify who is more at risk for OP and related complications. This paper provides an overview of the potential use of blood-related factors, such as platelet (PLT)- and monocyte-related factors, as biomarkers able to quickly screen, detect, and monitor OP in both sexes. Such biomarkers might be of key importance not only during the COVID-19 pandemic but also, even more importantly, during periods of better global health stability.
Identifiants
pubmed: 34246532
pii: S1043-2760(21)00120-X
doi: 10.1016/j.tem.2021.05.005
pmc: PMC8261630
pii:
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
672-679Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests Two authors (F.S. and M.F.) of the present manuscript patented the spontaneous osteoclastogenesis method (European Patent granted on 21 March 2018 n. 3008470 deriving from the regional phase of the international application published in WO2014/199331 A1) that was described in this manuscript. The other authors have no interests to declare.
Références
Osteoporos Int. 2017 May;28(5):1507-1529
pubmed: 28175979
Lancet Diabetes Endocrinol. 2017 Nov;5(11):908-923
pubmed: 28689768
Indian J Endocrinol Metab. 2014 Jul;18(4):449-54
pubmed: 25143898
J Bone Miner Res. 2006 Feb;21(2):292-9
pubmed: 16418785
J Cell Biochem. 2010 Mar 1;109(4):774-81
pubmed: 20052670
Biol Blood Marrow Transplant. 2016 Aug;22(8):1517-1524
pubmed: 27118572
J Pathol. 2002 Oct;198(2):220-7
pubmed: 12237882
Clin Sci (Lond). 2000 Aug;99(2):133-40
pubmed: 10918046
J Bone Joint Surg Am. 2020 Jun 17;102(12):e57
pubmed: 32341311
Saudi Med J. 2019 Apr;40(4):360-366
pubmed: 30957129
J Cell Physiol. 2016 Mar;231(3):521-30
pubmed: 26284737
Osteoporos Int. 2006 Dec;17(12):1726-33
pubmed: 16983459
J Phys Ther Sci. 2016 Jun;28(6):1753-8
pubmed: 27390409
Bone Res. 2015 Dec 01;3:15032
pubmed: 26664853
Science. 2000 Sep 1;289(5484):1508-14
pubmed: 10968781
J Endocrinol. 2002 Mar;172(3):673-81
pubmed: 11874715
Bone. 2008 Jul;43(1):92-100
pubmed: 18407820
Semin Thromb Hemost. 2012 Nov;38(8):797-807
pubmed: 23111860
Med Hypotheses. 2017 Nov;109:70-72
pubmed: 29150298
Panminerva Med. 2012 Sep;54(3):225-31
pubmed: 22801440
Lancet. 2020 Apr 25;395(10233):1315
pubmed: 32334687
Circ Res. 2018 Jan 19;122(2):337-351
pubmed: 29348254
J Clin Endocrinol Metab. 2013 Mar;98(3):946-53
pubmed: 23337726
Dis Markers. 2016;2016:7067984
pubmed: 27594735
Osteoporos Int. 2002;13(2):171-5
pubmed: 11905526
Osteoporos Int. 2020 Sep;31(9):1779-1786
pubmed: 32377806
Biomark Med. 2017 Jan;11(1):5-10
pubmed: 27917655
Biomolecules. 2020 Apr 11;10(4):
pubmed: 32290369
Am J Hematol. 2020 Jul;95(7):834-847
pubmed: 32282949
PLoS One. 2021 Mar 4;16(3):e0247330
pubmed: 33661911
J Bone Miner Res. 2020 Jun;35(6):1009-1013
pubmed: 32406536
Int J Mol Sci. 2020 Mar 04;21(5):
pubmed: 32143494
Br J Haematol. 2000 Nov;111(2):501-12
pubmed: 11122091
J Periodontol. 2005 Oct;76(10):1675-80
pubmed: 16253089
Int J Mol Sci. 2020 Nov 17;21(22):
pubmed: 33213099
Int J Mol Sci. 2020 Sep 21;21(18):
pubmed: 32967246
J Bone Miner Metab. 2012 Nov;30(6):660-5
pubmed: 22684618
Ther Adv Musculoskelet Dis. 2014 Oct;6(5):185-202
pubmed: 25342997
FASEB J. 2005 Mar;19(3):410-2
pubmed: 15611151
Nature. 1999 Nov 18;402(6759):304-9
pubmed: 10580503
BMJ. 2009 Nov 19;339:b4229
pubmed: 19926696
PLoS One. 2010 Jan 13;5(1):e8670
pubmed: 20107497
J Bone Miner Metab. 2015 Nov;33(6):701-7
pubmed: 25501698
Bone. 2013 Dec;57(2):399-404
pubmed: 24076251
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
Arthritis Rheum. 2001 May;44(5):1003-12
pubmed: 11352231
Bone. 2006 Nov;39(5):991-999
pubmed: 16782418
Osteoporos Int. 2014 Sep;25(9):2291-5
pubmed: 24923794
J Magn Reson Imaging. 2019 Apr;49(4):1029-1038
pubmed: 30252971
J Clin Endocrinol Metab. 1993 Dec;77(6):1648-53
pubmed: 8263153
Age (Dordr). 2015 Aug;37(4):9819
pubmed: 26250906
Blood. 2004 Dec 1;104(12):3722-30
pubmed: 15308561
Front Immunol. 2019 Mar 19;10:505
pubmed: 30941138
J Bone Miner Res. 1993 Dec;8 Suppl 2:S505-10
pubmed: 7510095
Anesth Analg. 2020 Aug;131(2):351-364
pubmed: 32433248
Arch Osteoporos. 2013;8:136
pubmed: 24113837
Biomolecules. 2020 Jun 18;10(6):
pubmed: 32570976
J Exp Med. 2011 Oct 24;208(11):2175-81
pubmed: 22006978
Osteoporos Int. 2020 Apr;31(4):801
pubmed: 32072205
Yonsei Med J. 2011 Sep;52(5):739-45
pubmed: 21786437
Ann Med Surg (Lond). 2020 Dec 13;61:88-92
pubmed: 33391762